Previous Article | Next Article ![]()
Journal of Virology, June 2001, p. 5119-5128, Vol. 75, No. 11
Department of Tumor Virology, Division of
Virology and Immunology, Medical Research Institute, Tokyo Medical and
Dental University, Bunkyo-ku, Tokyo 113-8510,1
Division of Plant Engineering, Kihara Institute for Biological
Research, Yokohama City University, Totsuka-ku, Yokoyama
244,2 and Cancer Genomics Division,
National Cancer Center Research Institute, Chuo-ku, Tokyo
104-0045,3 Japan
Received 27 November 2000/Accepted 1 March 2001
Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP)
is a phosphoprotein suggested to play important roles in EBV-induced
immortalization of B cells. One of the potential functions of EBNA-LP
is a cooperative induction with EBNA-2 of viral and cellular gene
expression, including that of the genes for viral latent membrane
protein 1 (LMP-1) and cellular cyclin D2. We report here that the
phosphorylation of EBNA-LP by cellular kinase(s) is critical to its
ability to cooperate with EBNA-2 in up-regulating the expression of
LMP-1 in a B-lymphoma cell line. Our conclusion is based on the
following observations. (i) Mass-spectrometric analysis of purified
EBNA-LP and mutational analyses of EBNA-LP revealed that the serine
residue at position 35 in the W2 repeat domain is the major
phosphorylation site of EBNA-LP in vivo. (ii) Substitutions of this
site in each W2 repeat domain with alanine markedly reduced the ability
of the protein to induce LMP-1 expression in combination with EBNA-2 in
Akata cells. (iii) Replacement at the major phosphorylation sites with
glutamic acids restored the wild-type phenotype. It is well established
that this substitution mimics constitutive phosphorylation. These
results indicated that the coactivator function of EBNA-LP is regulated
by phosphorylation.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.11.5119-5128.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification of Major Phosphorylation Sites of
Epstein-Barr Virus Nuclear Antigen Leader Protein (EBNA-LP): Ability of
EBNA-LP To Induce Latent Membrane Protein 1 Cooperatively with EBNA-2
Is Regulated by Phosphorylation

and
*
Corresponding author. Mailing address: Department of
Tumor Virology, Division of Virology and Immunology, Medical Research Institute, Tokyo Medical and Dental University, Yushima, Bunkyo-ku, Tokyo 113-8510, Japan. Phone: 81-3-5803-5816. Fax: 81-3-5803-0241. E-mail: kawaguchi.creg{at}mri.tmd.ac.jp.
This article is dedicated to the memory of Kanji Hirai.
Deceased.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|